Immune responses towards intestinal bacteria - Current concepts and future perspectives

Zeitschrift fur Gastroenterologie

Volumn 35, Issue 5, 1997, Pages 337-346

  Duchmann, R ^a   Neurath, M ^a   Marker Hermann E ^a   Meyer zum Buschenfelde K H ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Crohn's disease; enteroinvasive bacteria; enterotoxigenic bacteria; infection; intestinal flora; mucosal immunity; reactive arthritis; ulcerative colitis

Indexed keywords

CROHN DISEASE; ESCHERICHIA COLI; HUMAN; IMMUNE RESPONSE; INFECTION; INTESTINE FLORA; INTESTINE MUCOSA; REACTIVE ARTHRITIS; REVIEW; ULCERATIVE COLITIS; VIBRIO CHOLERAE; YERSINIA ENTEROCOLITICA;

ANTIGENS, BACTERIAL; ARTHRITIS, REACTIVE; CHOLERA; ENTEROBACTERIACEAE; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; IMMUNITY, CELLULAR; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; LYMPHOCYTE SUBSETS; PEYER'S PATCHES; VIBRIO CHOLERAE;

EID: 0030960427     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (78)

1. Mowat AM. The regulation of immune responses to dietary protein antigens. Immunol Today 1987; 93-8
2. Kelsall BL, Strober W. Host defenses at mucosal surfaces. In: Rich RR (ed.). Clinical Immunology. (Mosby: St. Louis) 1996; 299-332
3. Brandtzaeg P, Halstensen TS, Kett K et al. Immunobiology and immunopathology of human gut mucosa: Humoral immunity and intraepithelial lymphocytes. Gastroenterol 1989; 97: 1562-8
4. James SP, Zeitz M. Human gastrointestinal mucosal T cells. In: Ogra PL, Strober W (eds.). Hand-book of Mucosal Immunology (Academic Press: San Diego) 1994; 275-85
5. Kelsall B, Strober W. Distinct populations of dendritic cells are present in the subepithelial dome and T cell regions of the murine Peyers patch. J Exp Med 1996; 183: 237-47
6. Zeitz M, Schieferdecker HL, Ullrich R et al. Pheno-type and function of lamina propria T-lymphocytes. Immunol Res 1991; 10: 199-206
7. Zeitz M, Quinn TC, Graeff AS, James SP. Mucosal T cells provide helper function but do not proliferate when stimulated by specific antigen in lymphogranuloma venereum proctitis in nonhuman primates. Gastroenterology 1988; 94: 353-66
8. Dakin R. Remarks on a cutaneous affliction, produced by certain poisonous vegetables. Am J Med Sci 1829; 4: 98-100
9. Friedman A, Weiner HL. Induction of anergy or active suppression following oral tolerance is determined by antigen dose. PNAS 1994; 91: 6688-92
10. Chen Y, Inobe J, Marks R et al. Peripheral deletion of antigen-reactive ZT cells in oral tolerance. Nature 1995; 376: 177-80
11. Weiner HL, Friedman A, Miller A et al. Oral tolerance: Immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol 1994; 12: 809-17
12. Kaufmann SHE. Immune responses to intracellular bacteria. In: Rich RR (ed.). Clinical Immunology. (Mosby: St. Louis) 1996; 503-18
13. Simon GL, Gorbach SL. Intestinal flora in health arid disease. Gastroenterology 1984; 86: 174-93
14. Gorbach SL, Nahas L, Lerner PI, Weinstein L. Studies on intestinal microflora. I effects of diet, age. and periodic sampling on numbers of fecal mi croorganisms in man. Gastroenterology 1967; 53: 845-55
15. Zubrzycki L, Spaulding EH. Study on the stability of the normal fecal flora. J Bacteriol 1962; 83: 968-74
16. Moore WEG, Holdeman LV. Discussion of current bacteriologic investigations of the relationship between intestinal flora, diet, and colon cancer. Cancer Res 1975; 35: 3418-20
17. Abrams G, Bauer H, Sprinz H. Influence of the normal flora on mucosal morphology and cellular renewal in the ileum. A comparison of germ-free and conventional mice. Lab Invest 1963; 12: 355-64
18. Thompson G, Trexler P. Gastrointestinal structure and function in germ-free or gnotobiotic animals. Gut 1971: 12: 230-5
19. MacDonald TT, Carter PB. Requirement for a bacterial flora before mice generate cells capable of mediating the delayed hypersensitivity reaction to sheep red blood cells. J Immunol 1979; 122: 2624-9
20. Fearon DT, Locksley RM. The instructive role of innate immunity in the acquired immune response. Science 1996; 272: 50-4
21. Janeway CA. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol Today 1992; 13: 11-6
22. Evans DG, Silver RP, Evans DJ, Chase DG, Gorbach SL. Plasmid-controlled colonization factor associated with virulence in Escherichia coli enterotoxigenic for humans. Infect Immun 1975; 12: 656-67
23. Herringtion DA, Hall RH, Losonsky G et al. Toxin, toxin-coregulated pili and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans. J Exp Med 1989; 168: 1487
24. Richardson K, Kaper JB, Levine MM. Human immune response to Vibrio cholerae O1 whole cells and isolated outer membrane antigens. Infect Immun 1989; 57: 495-501
25. Mosley WH. The role of immunity in cholera. A review of epidemiological and serological studies. Texas Report Biol Med 1969; 27 (suppl. 1): 227
26. Winner L, Mack J, Weltzin R et al. New model for analysis of mucosal immunity: Intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholerae infection. Infect Immun 1991; 59: 977-82
27. Holmgren J, Lycke N, Czerkinsky C. Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems. Vaccine 1993; 11: 1179-84
28. Granfors K, Jalkanen S, von Essen R et al. Yersinia antigens in synovial fluid cells from patients with reactive arthritis. N Engl J Med 1989; 320: 216-21
29. Hanski C, Kutschka U, Schmoranzer HP et al. Immunohistochemical and electron microscopic study of the interaction of Yersinia enterocolitica serotype 08 with intestinal mucosa during experimental enteritis. Infect Immun 1989; 57: 673
30. Miller VI, Finlay BB, Falkow S. Factors essential for penetration of mammalian cells by Yersinia. Curr Top Microbiol Immunol 1988; 57: 121
31. Heesemann J, Gross U, Schmidt N, Laufs R. Immunohistochemical analysis of plasmid-encoded proteins released by enteropathogenic Yersinia sp. grown in calcium-deficient media. Infect Immun 1986; 54: 561-7
32. Stahlberg T, Heesemann J, Granfors K, Toivanen A. Immunohistochemical analysis of IgM, IgG, and IgA responses to plasmid encoded released proteins of Y. enterocolitica in patients with or without Yersinia triggered reactive arthritis. Ann Rheum Dis 1989; 48: 577-81
33. Lahesmaa R, Soderberg C, Bliska J et al. Pathogen antigen- and superantigen-reactive synovial fluid T cell in reactive arthritis. J Infect Dis 1995; 172: 1290-7
34. Probst P, Hermann E, Meyer zum Büschenfelde KH, Fleischer B. Identification of the Yersinia enterocolitica urease β subunit as a target antigen for human synovial T-lymphocytes in reactive arthritis. Infect Immun 1993; 61: 4507-9
35. Stuart PM, Woodward JG. Yersinia enterocolitica produces superantigenic activity. J Immunol 1992; 148: 225-33
36. Benjamin R, Parham P. HLA-B27 and disease: A consequence of inadvertent antigen presentation? Rheum Dis Clin North Am 1992; 18: 11-21
37. Hermann E, Yu DTY, Meyer zum Büschenfelde KH, Fleischer B. HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet 1993; 342: 646-50
38. Duchmann R, May E, Ackermann B et al. HLA-B27 restricted CTL responses are dominated by closely related TCR-Vβ gene segments. A study of Yersinia enterocolitica-specific and autoreactive synovial CD8+ T cells in reactive arthritis. Scand J Immunol 1996; 43: 101-8
39. May E, Duchmann R, Ackermann B, Meyer zum Büschenfelde KH, Märker-Hermann E. T cell receptor β junctional regions from HLA-B27-restricted T cells and HLA-B27 binding peptides display conserved hydropathy profiles in the absence of primary sequence homology. Int Immunology, 1996; 8: 1815-23
40. Hermann E, Fleischer B, Meyer zum Büschenfelde KH. Bacteria-specific cytotoxic CD8+ T cells: A missing link in the pathogenesis of the HLA-B27-associated spondylarthropathies. Ann Med 1994; 26: 365-9
41. Fiocchi C. Pathogenesis and clinical implications: Where do we stand, where do we go? In: Goebell H, Marchow H, Ewe K, Koelbel CH (ed.). Inflammatory bowel diseases. Progress in basic research and clinical implications (Kluwer Academic Publishers, Oxford) 1991
42. Bargan J. Experimental studies on the etiology of chronic ulcerative colitis. J Am Med Assoc 1924; 83: 332-6
43. Crohn B, Ginzburg L, Oppenheimer GD. Regional Ileitis: A pathogenic and clinical entity. JAMA 1932; 99: 1323-8
44. Chiodini R, Van Kruiningen H, Thayer W, Merkal S, Coutu J. Possible role of mycobacteria in inflammatory bowel disease. I. An unclassified mycobacterium species isolated from patients with Crohn's disease. Dig Dis Sci 1984; 29: 1073-9
45. Blaser MJ, Miller RA, Lacher J et al. Patients with active Crohn's disease have elevated serum antibodies to antigens from seven enteric bacterial pathogens. Gastroenterology 1984; 87: 888-94
46. Liu Y, Van Kruiningen H, West A et al. Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn's disease. Gastroenterology 1995; 108: 1396-1404
47. Fiocchi C, Battisto J, Farmer R. Studies on isolated gut mucosal lymphocytes in inflammatory bowel disease. Detection of activated T-cells and enhanced proliferation to Staphylococcus aureus and lipopoly-saccharides. Dig Dis Sci 1981; 26: 728-36
48. Ibbotson JP, Lowes JR, Chahal H et al. Mucosal cell-mediated immunity to mycobacterial, enterobacterial and other microbial antigens in inflammatory bowel disease. Clin Exp Immunol 1992; 87: 224-30
49. Pirzer U, Schönhaar A, Fleischer B, Hermann E, Meyer zum Büschenfelde KH. Reactivity of infiltrating T-lymphocytes with microbial antigens in Crohn's disease. Lancet 1991; 338: 1238-9
50. Duchmann R, Kaiser I, Märker-Hermann E, Meyer zum Büschenfelde KH. T cell clones from peripheral blood and human intestine are selective in their reactivity towards enterobacteria or H. pylori and isolated with increased frequency from inflamed in-flammatory bowel intestine. Scand J Immunol 1996; 44: 71-6
51. Duchmann R, Strober W, Fiocchi C, Ailing D, James SP. T cell receptor Vβ expression in inflammatory bowel disease lamina propria lymphocytes: Evidence for altered Vβ gene usage. Inflammatory Bowel Diseases 1995; 1: 184-92
52. Posnett D, Schmelkin I, Burton D et al. T cell antigen receptor V gene usage. Increases in Vβ8+ T cells in Crohn's disease. J Clin Invest 1990; 85: 1770-6
53. Bennet JD, Brinkman M. Treatment of ulcerative colitis by implantation of normal colonic flora. Lancet 1989; 1: 164
54. Foo MC, Lee A. Immunological response of mice to members of the autochthonous intestinal microflora. Infect Immun 1972; 6: 525-32
55. Berg R, Savage D. Immune response of specific pathogen-free and gnotobiotic mice to antigens of indigenous and non-indigenous microorganisms. Infect Immun 1975; 11: 320-9
56. Duchmann R, Kaiser I, Hermann E et al. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease. Clin Exp Immunol 1995; 102: 448-55
57. Duchmann R, Schmitt E, Knolle P, Meyer zum Büschenfelde KH, Neurath M. Tolerance towards resident intestinal flora in mice is abrogated in ex- perimental colitis and restored by treatment with Interleukin-10 antibodies to Interleukin-12. Eur J Immunol 1996; 26: 934-8
58. Protzer U, Duchmann R, Höhler T et al. Enteropathische Spondarthritiden bei chronisch entzündlichen Darmerkrankungen: Prävalenz, Befallsmuster und HLA-Assoziation. Med Klin 1996; 91: 330-5
59. Rutgeerts P, Goboes K, Peeters M et al. Effeet of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet 1991; 338: 771-4
60. Wyatt J, Vogelsang H, Hubl W, Waldhoer T, Lochs H. Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet 1993; 341: 1437
61. Sartor R, Cromartie W, Powell D, Schwab J. Granulomatous enterocolitis induced in rats by purified bacterial cell wall fragments. Gastroenterology 1985; 89: 587-95
62. Mee A, McLaughlin J, Hodgson H, Jewell D. Chronic immune colitis in rabbits. Gut 1979; 20: 1-5
63. Davis SW, Holt LC, Sartor RB. Luminal bacteria and bacterial polymers potentiate indomethacm-induced intestinal injury in rats, Gastroenterology 1990; 98: 444 A
64. Sadlack B, Merz H, Schorle H et al. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993; 75: 253-61
65. Kühn R, Löhler J, Rennick D, Rajewski K, Müller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993; 75: 263-74
66. Hammer RE, Maika SD, Richardson JA, Tang JP, Taurog JD. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: An animal model of HLA-B27-associated human disorders. Cell 1990; 63: 1099-112
67. Strober W, Ehrhardt RO. Chronic intestinal inflammation: An unexpected outcome in cytokine or T cell receptor mutant mice. Cell 1993; 75: 203-5
68. Reimann J, Rudolphi A, Claesson M. Novel experimental approaches in the study of the immunopathology in inflammatory bowel disease. J Mol Med 1995; 73: 133-40
69. Neurath M, Fuss I, Kelsall BL, Stüber E, Strober W. Antibodies to Interleukin-12 abrogate established experimental colitis in mice. J Exp Med 1995; 182: 1281-90
70. Holmgren J, Czerkinsky C. Cholera as a model for research on mucosal immunity and development of oral vaccines. Curr Opin Immunol 1992; 4: 387-91
71. Czerkinsky C, Svennerholm AM, Holmgren J. Induction and assessment of immunity at enteromucosal surfaces in humans: Implications for vaccine develop ment. Clin Infect Dis 1993; 16 (suppl. 2): 106-16
72. Märker-Hermann E, Duchmann R, May E, Ackermann B, Meyer zum Büschenfelde KH. The T cell receptor (TCR) in HLA-B27-restricted T cell responses - an introduction. Clinical Rheumatol 1996; 15 (suppl. 1): 86-90
73. Sartor R. Antimicrobial therapy of inflammatory bowel disease: Implications for pathogenesis and management. Can J Gastroenterol 1993; 7: 132-8
74. Sartor RB. Treating IBD alterating luminal contents: Rationale and response. In: Rachmilewith D (ed.). Inflammatory bowel diseases (Kluwer Academic, Lancaster) 1994; 177-91
75. Neurath M, Duchmann R, Meyer zum Büschenfelde K-H. Zytokine bei chronisch entzündlichen Darmerkrankungen. DMW 1996; 121: 735-41
76. Schreiber S, Kaftannig T, Thiele HG, Raedler A. Immunoregulatory role of interleukin-10 in patients with inflammatory bowel disease. Gastroenterology 1995; 108: 1434-44
77. Schwab JH. Suppression of the immune response by microorganisms. Bacteriological reviews 1975; 39: 121-43
78. Cowdery JS, Chace JH, Yi AK, Krieg AM. Bacterial DNA induce NK cells to produce IFN-γ in vivo and increases the toxicity of lipopolysacharides. J Immunol 1996; 156: 4570-5